The largest database of trusted experimental protocols

328 protocols using ls6500

1

Thymidine Salvage Pathway Assay in NSCLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
[3H]-thymidine (Perkin Elmer NET355001MC, PerkinElmer, Waltham, MA) was utilized for in vitro assessment of therapy-induced changes in thymidine salvage pathway activity in cultured human NSCLC cells. [3H]-thymidine specific activity was >10Ci(370GBq)/mmol and radiochemical purity >97%. H460 and H1299 cells were seeded (1×106/well) in 6-well plate in RPMI1640 supplemented with 10% FBS and antibiotics, incubated 24 hours in 5% CO2 at 37°C. When cell cultures achieved 80% confluence, cells were exposed to treatment with either the vehicle (sterile water), pemetrexed (100 nM), or the combination of pemetrexed (100 nM) and cisplatin (10 μM) in growth media for varying exposure times ranging up to 48 hours. Drug-containing medium was then removed, and the cells were then washed and pulsed with 5 μCi [3H]-thymidine/well for 1 hour. The cells were then washed and scraped into plastic vials. Scintillant (10 mL; Research Products International Corp., Mount Prospect, IL) was added to each vial and the radioactivity was counted on a scintillation counter (Beckman Coulter LS6500, Beckman Coulter Life Sciences, Indianapolis, IN).
+ Open protocol
+ Expand
2

Binding Assays of Opioid Ligands

Check if the same lab product or an alternative is used in the 5 most similar protocols
Binding assays were conducted on human MOR stably transfected into CHO cells (CHO-hMOR) according to the published procedure [43 (link)]. Cell membranes were prepared as described previously, and stored at −80 °C until use [43 (link)]. Protein concentration of cell membrane preparations was determined by the method of Bradford using bovine serum albumin as the standard [49 (link)]. Cell membranes (15–20 µg) were incubated in 50 mM Tris-HCl buffer (pH 7.4) with [3H]DAMGO (1 nM) and various concentrations of test peptides in a final volume of 1 mL, for 60 min at 25 °C. Non-specific binding was determined using 10 µM of unlabeled DAMGO. After incubation, reactions were terminated by rapid filtration through Whatman glass GF/C fiber filters. Filters were washed three times with 5 mL of ice-cold 50 mM Tris-HCl buffer (pH 7.4) using a Brandel M24R cell harvester (Gaithersburg, MD, USA). Radioactivity retained on the filters was counted by liquid scintillation counting using a Beckman Coulter LS6500 (Beckman Coulter Inc., Fullerton, CA, USA). The inhibitory constant (Ki, in nM) values were calculated from the competition binding curves by nonlinear regression analysis and the Cheng–Prusoff equation [50 (link)]. All experiments were performed in duplicate and repeated at least three times.
+ Open protocol
+ Expand
3

Comparing Liquid Scintillation Counting Systems

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sources were serially counted in all three of the commercial LS counting systems maintained by our group: a Beckman Coulter LS6500 (Beckman Coulter, Pasadena, CA), a Packard 2500TR, and a Wallac 1414 Guardian (both Perkin Elmer, Waltham, MA). Each source set was counted for 10 cycles of between 600 s and 900 s before being moved to the next counter. The total number of counts in each spectrum (open window) was more than 106. The sources were agitated before being inserted into each counter to ensure proper mixing.
Although the CNET technique was applied to these samples, no 3H tracing sources were prepared. Instead, efficiencies were calculated based on model calculations with estimated 3H efficiencies (see Sec. 3.4.1).
+ Open protocol
+ Expand
4

Opioid Receptor Binding Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Competitive binding assays were conducted on human opioid receptors stably transfected into CHO cells according to the published procedures [26 (link),27 (link)]. Binding assays were performed using [3H]DAMGO (1 nM), [3H]diprenorphine (0.2 nM), [3H]U69,593 (0.4 nM), or [3H]Nociceptin (0.1 nM) for labeling MOR, DOR, KOR, or NOP receptors, respectively. Non-specific binding was determined using 1–10 µM of the unlabeled counterpart of each radioligand. Assays were performed in 50 mM Tris-HCl buffer (pH 7.4) in a final volume of 1 mL. In NOP receptor experiments, 1 mg/mL bovine serum albumin (BSA) was added to the assay buffer. Cell membranes (15–20 µg) were incubated with various concentrations of test compounds and the appropriate radioligand for 60 min at 25 °C. After incubation, reactions were terminated by rapid filtration through Whatman GF/C glass fiber filters. In the NOP receptor assay, filtration was carried out through 0.5% PEI-soaked Whatman GF/C glass fiber filters. Filters were washed three times with 5 mL of ice-cold 50 mM Tris-HCl buffer (pH 7.4) using a Brandel M24R cell harvester (Gaithersburg, MD, USA). Radioactivity retained on the filters was counted by liquid scintillation counting using a Beckman Coulter LS6500 (Beckman Coulter Inc., Fullerton, CA, USA). All experiments were performed in duplicate and repeated three times with independently prepared samples.
+ Open protocol
+ Expand
5

Thymidine Salvage Pathway Assay in NSCLC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
[3H]-thymidine (Perkin Elmer NET355001MC, PerkinElmer, Waltham, MA) was utilized for in vitro assessment of therapy-induced changes in thymidine salvage pathway activity in cultured human NSCLC cells. [3H]-thymidine specific activity was >10Ci(370GBq)/mmol and radiochemical purity >97%. H460 and H1299 cells were seeded (1×106/well) in 6-well plate in RPMI1640 supplemented with 10% FBS and antibiotics, incubated 24 hours in 5% CO2 at 37°C. When cell cultures achieved 80% confluence, cells were exposed to treatment with either the vehicle (sterile water), pemetrexed (100 nM), or the combination of pemetrexed (100 nM) and cisplatin (10 μM) in growth media for varying exposure times ranging up to 48 hours. Drug-containing medium was then removed, and the cells were then washed and pulsed with 5 μCi [3H]-thymidine/well for 1 h. The cells were then washed and scraped into plastic vials. Scintillant (10 ml; Research Products International Corp., Mount Prospect, IL) was added to each vial and the radioactivity was counted on a scintillation counter (Beckman Coulter LS6500, Beckman Coulter Life Sciences, Indianapolis, IN). For ENT1 inhibition, cells were incubated with NBMPR (Nitrobenzylthioinosine) for 15min (100uM; Sigma-Aldrich, St. Louis, MO) prior to labeling with [3H]-thymidine.
+ Open protocol
+ Expand
6

Biodistribution of Radiolabeled Sunitinib

Check if the same lab product or an alternative is used in the 5 most similar protocols
Solid melanoma tumors were developed in C57BL/6 mice by subcutaneous inoculation of 2×105 B16F10 cells into the right flank of the mice. When the tumors grew to approximately 300 mm3, tumor-bearing mice were treated i.v. with a single dose of 10 mg/kg SUNb-PM containing 3H-labeled sunitinib base (TFA salt was neutralized by triethylamine) or treated p.o. with a single dose of 30 mg/kg SUNOS containing 3H-labeled sunitinib TFA salt. In both the i.v. and p.o. groups, the dose of 3H-labeled sunitinib was fixed at 50 μCi/kg. The mice were sacrificed six h, 12 h, and 24 h post-i.v. or p.o. administration. Tumor tissue samples were first digested by Tissue Solubilizer (Amersham Biosciences Corp. NJ, USA) overnight at room temperature and then added to four mL of scintillation cocktail (Thermo Fisher Scientific Inc., MA, USA). The samples were then assayed using a liquid scintillation counter (Beckman coulter LS6500). The percentage of the administrated dose (% ID) in the tissue was calculated and normalized to the total weight of each organ. All tests were done in triplicate.
+ Open protocol
+ Expand
7

Biodistribution of Radiolabeled PLGA NPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 mice bearing B16F10 tumors were i.v. administered with a single dose of 1 µCi 3H-labeled PLGA NP and were sacrificed 24 h post-intravenous administration. Tissue samples were first digested by Tissue Solubilizer (Amersham Biosciences Corp. NJ, USA) overnight at room temperature and then with 4 mL scintillation cocktail (Thermo Fisher Scientific Inc., MA, USA). The samples were then assayed using a liquid scintillation counter (Beckman coulter LS6500). The percentage of the injected dose (% ID) in the tissue was calculated. All tests were done in triplicate.
+ Open protocol
+ Expand
8

Radiolabeled Tracer Efficiency Calculations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sources for CNET were prepared in standard (clear) 22 mL glass scintillation vials with foil-lined caps. Efficiency calculations relied on the same MICELLE2 model used for TDCR (see section 2.2.1 and Table 2). For CNET, efficiency variation was achieved by chemical quenching with nitromethane and all 224Ra sources were measured against matched 3H sources. The 3H sources were prepared using a gravimetric dilution of NIST tritiated-water (Hydrogen-3) standard SRM 4927g (NIST 2015 ; Collé et al., 2016 (link)).
Samples were measured on a Beckman Coulter LS6500 (Beckman Coulter, Fullerton, CA, USA) and a Packard Tri-Carb 4910 (PerkinElmer, Waltham, MA, USA), with consistent results. The samples covered a range of 3H counting efficiencies (εH-3) of (0.28 to 0.46) counts per 3H decay, corresponding to a range of 224Ra counting efficiencies (εRa-224) of (5.66 to 5.68) counts per 224Ra decay. Over this range, our calculated 224Ra efficiencies were 0.023 % to 0.035 % lower than those estimated using the polynomial given by Kossert and Nähle (2011) . Calculated activities showed no trending with time or traced efficiency.
+ Open protocol
+ Expand
9

Quantifying Tracer Extraction from Wood

Check if the same lab product or an alternative is used in the 5 most similar protocols
After the exposure, wood samples were sheared with a hammer and knife into four equal parts (~1.25 × 2.5 × 1.5 cm 3 ), where parts A and D were those originally located next to the end-grain side whereas parts B and C were the two middle sections (Figure 1). Each wood part was further sheared into smaller pieces to allow for an exhaustive TAZ extraction, which was carried out for 16 hours using a Soxhlet apparatus with 130.0 mL of acetone. The extract was evaporated to dryness using a vacuum rotary evaporator and reconstituted in 1.5 mL of acetone. For the liquid scintillation counting analysis, 1.5 mL of an acetone dissolved sample was vortexed with 3.5 mL of the scintillation cocktail and analyzed after an overnight equilibration in a scintillation counter, Beckman Coulter LS 6500, purchased from Beckman Coulter, Inc. (Fullerton, CA, USA). The analysis was run in duplicate for 10.0 min in a DPM calculation mode (disintegrations per minute, which is directly proportional to the tracer concentration).
Water run-off was collected several times per week and the volume was recorded.
As with the wood extracts, run-off water was evaporated to dryness using a vacuum rotary evaporator and reconstituted in 1.5 mL of acetone, which was analyzed using a scintillation counting analysis as described previously.
+ Open protocol
+ Expand
10

Quantifying Cellular Lipid and Histone Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
BN cells were cultured with 0.5 µCi of [ 3 H]-acetyl-CoA (Perkin Elmer, Waltham, MA) in 1 mL of complete media for 24 hours. Media was collected in separate tubes and the pellets were washed three times with PBS. The cell pellets were fully solubilized with 200 µl of a 3% solution of potassium hydroxide (KOH) (29) . Solubilized cell pellets were then extracted for their lipid using 1ml of a 2:1 (v/v) chloroform:methanol solution, similar to the Folch method (without the neutralization step with acid/chloride salt) (Folch, Lees, & Stanley, 1957) . Histones were prepared directly from cell pellets using a histone extraction kit according to the manufacturer's instructions (Abcam, Toronto, ON). Disintegrations per minute (DPM) were determined using a LS6500 scintillation counter (Beckman Coulter, Ramsey, MN) using 10 µl from either solubilized cell pellets, lipid extracts and histone extracts.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!